Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Carrier Proteins
Carrier Proteins
Chronic Disease
Chronic Disease
Double-Blind Method
Double-Blind Method
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Platelet Count
Platelet Count
Purpura, Thrombotic Thrombocytopenic
Purpura, Thrombotic Thrombocytopenic
Receptors, Fc
Receptors, Fc
Recombinant Fusion Proteins
Recombinant Fusion Proteins
Splenectomy
Splenectomy
Thrombopoietin
Thrombopoietin
Treatment Outcome
Treatment Outcome
authors with profiles
James N George